NCT02178722 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Approximately 54 months
- Other-event reporting threshold
- 5%
The safety evaluable population included all participants enrolled in the study who received at least 1 dose of study drug (epacadostat or pembrolizumab).
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Phase 1: Epacadostat 25 mg BID | 0 / 4 | 4 / 4 | 2 / 4 |
| Phase 1: Epacadostat 50 MG BID | 8 / 20 | 18 / 20 | 13 / 20 |
| Phase 1: Epacadostat 100 MG BID | 9 / 18 | 17 / 18 | 12 / 18 |
| Phase 1: Epacadostat 300 MG BID | 9 / 20 | 20 / 20 | 14 / 20 |
| Phase 2: Epacadostat 100 MG BID | 195 / 382 | 375 / 382 | 209 / 382 |
| Total | 221 / 444 | 434 / 444 | 250 / 444 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 12
- num At Risk
- 382
- num Events
- 13
- group Id
- EG005
- num Affected
- 14
- num At Risk
- 444
- num Events
- 15
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute coronary syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute hepatic failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 382
- num Events
- 8
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 8
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 444
- num Events
- 6
- term
- Acute respiratory failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Adult failure to thrive
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 382
- num Events
- 5
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 444
- num Events
- 6
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 382
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 444
- num Events
- 3
- term
- Anxiety
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Aphasia
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 11
- num At Risk
- 382
- num Events
- 12
- group Id
- EG005
- num Affected
- 12
- num At Risk
- 444
- num Events
- 13
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 20
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 20
- num Events
- 3
- group Id
- EG004
- num Affected
- 19
- num At Risk
- 382
- num Events
- 19
- group Id
- EG005
- num Affected
- 25
- num At Risk
- 444
- num Events
- 25
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 18
- num Events
- 3
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 20
- num Events
- 4
- group Id
- EG004
- num Affected
- 53
- num At Risk
- 382
- num Events
- 60
- group Id
- EG005
- num Affected
- 59
- num At Risk
- 444
- num Events
- 68
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 7
- term
- Abdominal pain lower
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 23
- num At Risk
- 382
- num Events
- 25
- group Id
- EG005
- num Affected
- 25
- num At Risk
- 444
- num Events
- 27
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 444
- num Events
- 2
- term
- Actinic keratosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 7
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 9
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 382
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute sinusitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 20
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 18
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 36
- num At Risk
- 382
- num Events
- 46
- group Id
- EG005
- num Affected
- 42
- num At Risk
- 444
- num Events
- 54
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 9
- num At Risk
- 444
- num Events
- 9
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 382
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Alopecia areata
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 382
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 444
- num Events
- 3
- term
- Amnesia
Complete source fields
- description
- The safety evaluable population included all participants enrolled in the study who received at least 1 dose of study drug (epacadostat or pembrolizumab).
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 4
- description
- Epacadostat 25 mg tablet orally twice daily (BID) starting on Cycle 1 Day 1 in combination with pembrolizumab 2 mg/kg administered intravenously every 3 weeks (Q3W) starting on Cycle 1 Day 1.
- id
- EG000
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 0
- serious Num At Risk
- 4
- title
- Phase 1: Epacadostat 25 mg BID
- deaths Num Affected
- 13
- deaths Num At Risk
- 20
- description
- Epacadostat 50 mg tablet orally BID starting on Cycle 1 Day 1 in combination with pembrolizumab 2 mg/kg or 200mg administered intravenously every 3 weeks (Q3W) starting on Cycle 1 Day 1.
- id
- EG001
- other Num Affected
- 18
- other Num At Risk
- 20
- serious Num Affected
- 8
- serious Num At Risk
- 20
- title
- Phase 1: Epacadostat 50 MG BID
- deaths Num Affected
- 12
- deaths Num At Risk
- 18
- description
- Epacadostat 100 mg tablet orally BID starting on Cycle 1 Day 1 in combination with pembrolizumab 2 mg/kg or 200mg administered intravenously every 3 weeks (Q3W) starting on Cycle 1 Day 1
- id
- EG002
- other Num Affected
- 17
- other Num At Risk
- 18
- serious Num Affected
- 9
- serious Num At Risk
- 18
- title
- Phase 1: Epacadostat 100 MG BID
- deaths Num Affected
- 14
- deaths Num At Risk
- 20
- description
- Epacadostat 300 mg tablet orally BID starting on Cycle 1 Day 1 in combination with pembrolizumab 2 mg/kg or 200mg administered intravenously every 3 weeks (Q3W) starting on Cycle 1 Day 1
- id
- EG003
- other Num Affected
- 20
- other Num At Risk
- 20
- serious Num Affected
- 9
- serious Num At Risk
- 20
- title
- Phase 1: Epacadostat 300 MG BID
- deaths Num Affected
- 209
- deaths Num At Risk
- 382
- description
- Epacadostat 100 mg tablet orally BID in combination with pembrolizumab 200 mg intravenously every 3 weeks (Q3W).
- id
- EG004
- other Num Affected
- 375
- other Num At Risk
- 382
- serious Num Affected
- 195
- serious Num At Risk
- 382
- title
- Phase 2: Epacadostat 100 MG BID
- deaths Num Affected
- 250
- deaths Num At Risk
- 444
- description
- Total
- id
- EG005
- other Num Affected
- 434
- other Num At Risk
- 444
- serious Num Affected
- 221
- serious Num At Risk
- 444
- title
- Total
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 11
- num At Risk
- 382
- num Events
- 12
- group Id
- EG005
- num Affected
- 12
- num At Risk
- 444
- num Events
- 13
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 20
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 20
- num Events
- 3
- group Id
- EG004
- num Affected
- 19
- num At Risk
- 382
- num Events
- 19
- group Id
- EG005
- num Affected
- 25
- num At Risk
- 444
- num Events
- 25
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 18
- num Events
- 3
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 20
- num Events
- 4
- group Id
- EG004
- num Affected
- 53
- num At Risk
- 382
- num Events
- 60
- group Id
- EG005
- num Affected
- 59
- num At Risk
- 444
- num Events
- 68
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 7
- term
- Abdominal pain lower
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 23
- num At Risk
- 382
- num Events
- 25
- group Id
- EG005
- num Affected
- 25
- num At Risk
- 444
- num Events
- 27
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 444
- num Events
- 2
- term
- Actinic keratosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 7
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 9
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 382
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute sinusitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 20
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 18
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 36
- num At Risk
- 382
- num Events
- 46
- group Id
- EG005
- num Affected
- 42
- num At Risk
- 444
- num Events
- 54
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 9
- num At Risk
- 444
- num Events
- 9
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 382
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Alopecia areata
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 382
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 444
- num Events
- 3
- term
- Amnesia
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG004
- num Affected
- 12
- num At Risk
- 382
- num Events
- 13
- group Id
- EG005
- num Affected
- 14
- num At Risk
- 444
- num Events
- 15
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute coronary syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute hepatic failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 382
- num Events
- 8
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 444
- num Events
- 8
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Acute myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 382
- num Events
- 6
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 444
- num Events
- 6
- term
- Acute respiratory failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Adult failure to thrive
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 20
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 382
- num Events
- 5
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 444
- num Events
- 6
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 18
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 382
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 444
- num Events
- 3
- term
- Anxiety
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA 20.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 18
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 20
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 382
- num Events
- 1
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 444
- num Events
- 1
- term
- Aphasia
- time Frame
- Approximately 54 months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle